Cidara Therapeutics’ investigational long-acting antiviral, CD388, has achieved statistically significant [...]

Cereno Scientific, a biotechnology company pioneering treatments for rare cardiovascular [...]

Qureight’s deep-learning biomarkers confirm representativeness of Insilico’s Phase 2a IPF [...]

Cabotegravir and rilpivirine long-acting treatment proves highly effective and widely [...]

Collaboration targets faster, lower-cost production of RNA-based therapies with reduced [...]

Lead multiple myeloma candidate enters Cohort 8; second asset dosed [...]

Merck to broaden use of Certara’s Pinnacle 21 platform, adding [...]

Ciloa, a pioneer in bioengineering extracellular vesicles (EVs) for innovative [...]

Backing from Shawbrook follows rapid customer growth and positions Optibrium [...]

RNA therapeutics biotech Ochre Bio has appointed its founder and [...]